|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����� |
|
��·��Ⱦ |
| ��������������� | |
|
��� |
|
֣���� |
| PubMed | |
|
Article by |
|
Article by |
���������·��Ⱦ
���, ֣����
�й�ҽѧ��ѧԺ, �й�Э��ҽ�ƴ�ѧ����Э��ҽԺƤ����, ����100730
������,���Ŵ�����������صĹ㷺Ӧ��,������������·��Ⱦ��������������,�ڲμ��Դ�����������Ļ�����,�������Ⱦ������������Ҳ�������ӡ����������·��Ⱦ�ij�����ԭ���ǰ������,����������зǰ�������������·��ȾҲ�ܳ��������������·��Ⱦ�������Ȼ������Һ�����������Һ�������,��Ҫ�����ٴ����ֺ�Ⱦ��λ��ѡ�����˵����Ʒ�����
[2] Okafor JI, O NO. Some pathogenic fungi involved in serious cases of urinary tract infections in Nigeria. J Commun Dis, 1997, 29 (2):101-107.
[3] Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System. Am J Cardiol, 1998, 82(6):789-793.
[4] Febre N, Silva V, Medeiros EA, et al. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol, 1999, 37 (5):1584-1586.
[5] Hsueh PR, Chen ML, Sun CC, et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis, 2002, 8(1):63-68.
[6] Krcmery S, Dubrava M, Krcmery V Jr. Fungal urinary tract infections in patients at risk. Int J Antimicrob Agents, 1999, 11 (3-4):289-291.
[7] Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis, 2000, 30(1):14-18.
[8] Lefevre JC, Lepargneur JP, Bauriaud R, et al. Clinical and microbiologic features of urethritis in men in Touloue, France. Sex Transm Dis, 1991, 18(2):76-79.
[9] Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria:a randomized, double-blind study of treatment with fluconazole and placebo.The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis, 2000,30(1):19-24.
[10] Schwab U, Chernomas F, Larcom L,et al. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients. Diagn Microbiol Infect Dis, 1997, 29(1):11-17.
[11] Lundstrom T, Sobel J. Nosocomial candiduria:a review. Clin Infect Dis. 2001, 32(11):1602-1607.
[12] Fisher JF, Newman CL, Sobel JD. Yeast in the urine:solutions for a budding problem. Clin Infect Dis, 1995, 20(1):183-189.
[13] Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World J Urol. 1999, 17(6):410-414.
[14] Fisher JF. Candiduria:When and How to Treat It. Curr Infect Dis Rep, 2000, 2(6):523-530.
[15] Jacobs LG, Skidmore EA, Freeman K, et al. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis, 1996,22(1):30-35.
[16] Fan-Havard P, ODonovan C, Smith SM, et al. Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria. Clin Infect Dis, 1995, 21(4):960-965.
[17] Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis, 2000, 30(4):662-678.
[18] Boedeker KS, Kilzer WJ. Fluconazole dose recommendation in urinary tract infection. Ann Pharmacother, 2001,35 (3):369-372.
[19] Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis, 1990, 12 (Suppl 3):S318-S326.